International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 458-462 doi: 10.5281/zenodo.16786437
Original Article
Comparative Study of Autologous Platelet Rich Plasma Versus Normal Saline Wound Dressing in Diabetic Foot Ulcer
Published
Aug. 9, 2025
Abstract

Introduction: Diabetic foot ulcers (DFUs) are a debilitating complication of diabetes mellitus, characterized by chronic non-healing wounds that may lead to hospitalization or amputation. Optimizing wound healing strategies is crucial to reduce morbidity. Platelet-rich plasma (PRP), rich in growth factors, has emerged as a novel therapeutic adjunct to promote wound healing.

Objective: This study compares the effectiveness of autologous PRP dressing versus conventional normal saline (NS) dressing in promoting wound healing among patients with diabetic foot ulcers.

Methods: A prospective randomized controlled study was conducted at the Department of Surgery, TMMC&RC, Moradabad, over 18 months. Seventy-four patients with diabetic foot ulcers (Wagner Grades 1–3) were randomized into two groups: Group A received PRP dressings; Group B received NS dressings. PRP was prepared via double centrifugation and applied weekly. Wound healing was assessed by reduction in ulcer size, granulation tissue formation, and duration of hospital stay.

Results: Patients in the PRP group demonstrated a statistically significant faster rate of wound healing compared to the NS group. On day 7, 100% of PRP patients showed granulation tissue versus 62% in the NS group. Mean healing time and hospital stay were significantly reduced in the PRP group. No adverse events were noted.

Conclusion: Autologous PRP dressing significantly accelerates wound healing in diabetic foot ulcers compared to normal saline. It is safe, easy to prepare, and cost-effective, offering a promising alternative for managing chronic wounds in diabetic patients

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2204 Views
249 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved